DE69424577D1 - Mitomycin enthaltende arzneimittelabgabesysteme - Google Patents

Mitomycin enthaltende arzneimittelabgabesysteme

Info

Publication number
DE69424577D1
DE69424577D1 DE69424577T DE69424577T DE69424577D1 DE 69424577 D1 DE69424577 D1 DE 69424577D1 DE 69424577 T DE69424577 T DE 69424577T DE 69424577 T DE69424577 T DE 69424577T DE 69424577 D1 DE69424577 D1 DE 69424577D1
Authority
DE
Germany
Prior art keywords
mmc
pct
groups
carrier polymer
spacer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69424577T
Other languages
English (en)
Other versions
DE69424577T2 (de
Inventor
Etienne Honore Schacht
Paolo Ferruti
Ruth Duncan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
European Community EC Luxemburg
Original Assignee
European Community EC Luxemburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by European Community EC Luxemburg filed Critical European Community EC Luxemburg
Publication of DE69424577D1 publication Critical patent/DE69424577D1/de
Application granted granted Critical
Publication of DE69424577T2 publication Critical patent/DE69424577T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69424577T 1993-08-18 1994-08-17 Mitomycin enthaltende arzneimittelabgabesysteme Expired - Fee Related DE69424577T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9317213A GB2282384B8 (en) 1993-08-18 1993-08-18 Drug delivery agents incorporating mitomycin
PCT/IB1994/000259 WO1995005200A1 (en) 1993-08-18 1994-08-17 Drug delivery agents incorporating mitomycin

Publications (2)

Publication Number Publication Date
DE69424577D1 true DE69424577D1 (de) 2000-06-21
DE69424577T2 DE69424577T2 (de) 2001-02-22

Family

ID=10740702

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69424577T Expired - Fee Related DE69424577T2 (de) 1993-08-18 1994-08-17 Mitomycin enthaltende arzneimittelabgabesysteme

Country Status (12)

Country Link
US (1) US5738864A (de)
EP (1) EP0804246B1 (de)
JP (1) JPH09501674A (de)
AT (1) ATE192933T1 (de)
CA (1) CA2168007C (de)
DE (1) DE69424577T2 (de)
DK (1) DK0804246T3 (de)
ES (1) ES2145832T3 (de)
GB (1) GB2282384B8 (de)
GR (1) GR3034174T3 (de)
PT (1) PT804246E (de)
WO (1) WO1995005200A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5850855A (en) * 1990-01-09 1998-12-22 Ems-Inventa Ag Flexible coolant conduit and method of making same
IL131162A0 (en) * 1997-02-26 2001-01-28 Lilly Co Eli Selective epoxidation process for preparing pharmaceutical compounds
US6251866B1 (en) 1997-08-05 2001-06-26 Watson Laboratories, Inc. Conjugates targeted to the interleukin-2 receptor
KR20010090602A (ko) * 1998-10-30 2001-10-18 스즈키 다다시 디디에스 화합물 및 그의 측정방법
US7220414B2 (en) * 2000-09-06 2007-05-22 A.P. Pharma, Inc. Degradable polyacetal polymers
US20030124742A1 (en) * 2001-08-22 2003-07-03 Prakash Ramesh K. Conjugates targeted to target receptors
EP1620060B1 (de) * 2003-04-29 2010-03-24 The General Hospital Corporation Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
WO2006020719A2 (en) * 2004-08-11 2006-02-23 Arqule, Inc. Aminoacid conjugates of beta - lapachone for tumor targeting
US8614228B2 (en) 2004-08-11 2013-12-24 Arqule, Inc. Quinone prodrug compositions and methods of use
US20070128118A1 (en) 2005-12-05 2007-06-07 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
JP5286822B2 (ja) * 2007-02-22 2013-09-11 Ｊｓｒ株式会社 ポリアミノ酸またはポリアミノ酸系共重合体の製造方法
WO2008124735A2 (en) * 2007-04-10 2008-10-16 Nitto Denko Corporation Multi-functional polyglutamate drug carriers
CN101687835B (zh) 2007-04-30 2015-08-19 艾科尔公司 苯醌化合物的羟基磺酸盐和它们的应用
EP2155253A2 (de) * 2007-05-09 2010-02-24 Nitto Denko Corporation Polyglutamatkonjugate und polyglutamat-aminosäure-konjugate mit mehreren wirkstoffen
CN101678123B (zh) * 2007-05-09 2014-07-16 日东电工株式会社 包含疏水性化合物和聚氨基酸结合物的组合物
CN101730549B (zh) * 2007-05-09 2015-12-09 日东电工株式会社 与铂类药物结合的聚合物
JP2011513412A (ja) * 2008-03-06 2011-04-28 日東電工株式会社 ポリマーパクリタキセル結合体を含む癌を治療するための薬学組成物
EP3655039A1 (de) * 2017-07-17 2020-05-27 Technische Universiteit Eindhoven Anwendbare chemische zusammensetzung mit einem an eine hydrophobe gruppe konjugierten mittel und einem träger

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
JP2528477B2 (ja) * 1987-09-07 1996-08-28 三共株式会社 高分子制癌剤の増強剤
AU628846B2 (en) * 1988-08-23 1992-09-24 Georgetown University Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof
JPH0762049B2 (ja) * 1991-03-18 1995-07-05 工業技術院長 高分子マイトマイシンｃ誘導体及びその製造方法
JPH05252673A (ja) * 1992-03-05 1993-09-28 Honda Motor Co Ltd 電源装置

Also Published As

Publication number Publication date
GB2282384B8 (en) 1997-09-04
CA2168007A1 (en) 1995-02-23
CA2168007C (en) 2001-06-12
US5738864A (en) 1998-04-14
ES2145832T3 (es) 2000-07-16
GB2282384A (en) 1995-04-05
DE69424577T2 (de) 2001-02-22
GB9317213D0 (en) 1993-10-06
GB2282384B (en) 1997-09-03
PT804246E (pt) 2000-08-31
EP0804246B1 (de) 2000-05-17
WO1995005200A1 (en) 1995-02-23
EP0804246A1 (de) 1997-11-05
GR3034174T3 (en) 2000-11-30
ATE192933T1 (de) 2000-06-15
JPH09501674A (ja) 1997-02-18
DK0804246T3 (da) 2000-11-13

Similar Documents

Publication Publication Date Title
DE69424577T2 (de) Mitomycin enthaltende arzneimittelabgabesysteme
DE59609501D1 (de) Kristallmodifikation des CDCH, Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE69331149T2 (de) Gerät zum injizieren eines pharmazeutischen präparats in festem zustand
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
SE9300140D0 (sv) Solid substrate
DK1028707T3 (da) Oftalmiske præparater med forlænget frigivelse og indeholdende vandopløselige medikamenter
ES2130423T3 (es) Sistema de administracion intravaginal.
BR9406455A (pt) Seringa sem agulha embalagem estéril produto para uso terapêutico e processo de tratamento terapêutico
PL326149A1 (en) Pharmaceutic dipeptides containing angiostatic agents and methods of their application
FI970788A (fi) Kasveilla käytettäviksi tarkoitettuja suihkutettavissa olevia, kalvon muodostavia järjestelmiä vaikuttavien aineiden antamiseksi
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
UY24512A1 (es) Desnaturalizantes de sales de amina simpatomimeticas
HK1000595A1 (en) Preparation of optically active hydrazines and amines
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
AU4049399A (en) Novel use of hiv protease inhibiting compounds
ID23424A (id) Glikokonjugat dari 20(s)-kamptotesin
GEP20022680B (en) Carbocyclic Nucleoside Hemisulfate, Method for Its Production, Its Use for Treatment of Viral Infections and Pharmaceutical Composition Containing the Same
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
FI961054A (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
FI963567A0 (fi) Diklofenakki-Na:a sisältävä depottabletti
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
AU2796295A (en) New derivatives of oligosides, their process of preparation and their applications
PL315619A1 (en) Oral form of a drug containing acid active substances and method of obtaining same
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: ZEITLER, VOLPERT, KANDLBINDER, 80539 MUENCHEN

8339 Ceased/non-payment of the annual fee